P2 receptors in macrophage fusion and osteoclast formation

Purinergic Signalling

Volumn 3, Issue 1-2, 2007, Pages 53-57

  Steinberg, Thomas H ^a,b   Hiken, Jeffrey F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

Giant cell formation; Osteoclast; Purinergic receptors

Indexed keywords

EID: 33947668825     PISSN: 15739538     EISSN: 15739546     Source Type: Journal    
DOI: 10.1007/s11302-006-9036-9     Document Type: Article

References (32)

1. Anderson JM (2000) Multinucleated giant cells. Curr Opin Hematol 7(1):40-47
2. Cui W, Zhang KJ, Zhang Q, Ke HZ, Chalouni C, Vignery A (2005) The intracellular domain of CD44 promotes the fusion of macrophages. Blood 107(2):796-805
3. Sterling H, Saginario C, Vignery A (1998) CD44 occupancy prevents macrophage multinucleation. J Cell Biol 143(3):837-847
4. Saginario C, Sterling H, Beckers C, Kobayashi R, Solimena M, Ullu E et al (1998) MFR, a putative receptor mediating the fusion of macrophages. Mol Cell Biol 18(11):6213-6223
5. Han X, Sterling H, Chen Y, Saginario C, Brown EJ, Frazier WA et al (2000) CD47, a ligand for the macrophage fusion receptor, participates in macrophage multinucleation. J Biol Chem 275(48):37984-37992
6. Ohgimoto S, Tabata N, Suga S, Nishio M, Ohta H, Tsurudome M et al (1995) Molecular characterization of fusion regulatory protein-1 (FRP-1) that induces multinucleated giant cell formation of monocytes and HIV gp160-mediated cell fusion. FRP-1 and 4F2/CD98 are identical molecules. J Immunol 155(7):3585-3592
7. Namba K, Nishio M, Mori K, Miyamoto N, Tsurudome M, Ito M et al (2001) Involvement of ADAM9 in multinucleated giant cell formation of blood monocytes. Cell Immunol 213(2):104-113
8. Kukita T, Wada N, Kukita A, Kakimoto T, Sandra F, Toh K et al (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J Exp Med 200(7):941-946
9. Yagi M, Miyamoto T, Sawatani Y, Iwamoto K, Hosogane N, Fujita N et al (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J Exp Med 202(3):345-351
10. Falzoni S, Munerati M, Ferrari D, Spisani S, Moretti S, Di VF (1995) The purinergic P2Z receptor of human macrophage cells. Characterization and possible physiological role. J Clin Invest 95(3):1207-1216
11. 7 receptor. J Cell Biol 138(3):697-706
12. 7 receptor function with a monoclonal antibody. Blood 92(10):3521-3528
13. Falzoni S, Chiozzi P, Ferrari D, Buell G, Di VF (2000) P2X(7) receptor and polykarion formation. Mol Biol Cell 11(9):3169-3176
14. Mizuno K, Okamoto H, Horio T (2001) Heightened ability of monocytes from sarcoidosis patients to form multi-nucleated giant cells in vitro by supernatants of concanavalin A-stimulated mononuclear cells. Clin Exp Immunol 126(1):151-156
15. Yu H, Ferrier J (1994) Mechanisms of ATP-induced Ca2+ signaling in osteoclasts. Cell Signal 6:905-914
16. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR (2000) Expression of P2 receptors in bone and cultured bone cells. Bone 27(4):503-510
17. Bowler WB, Birch MA, Gallagher JA, Bilbe G (1995) Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts. J Bone Miner Res 10:1137-1145
18. 7 receptor inhibits formation of multinucleated human osteoclasts in vitro. Calcif Tissue Int 73(4):361-369
19. Solle M, Labasi J, Perregaux DG, Stam E, Petrushova N, Koller BH et al (2001) Altered cytokine production in mice lacking P2X(7) receptors. J Biol Chem 276(1):125-132
20. 7 nucleotide receptor reveals its regulatory roles in bone formation and resorption. Mol Endocrinol 17:1356-1367
21. 7 receptor-deficient mice. Crit Rev Eukaryot Gene Expr 13(2-4):243-253
22. Schilling WP, Wasylyna T, Dubyak GR, Humphreys BD, Sinkins WG (1999) Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore. Am J Physiol 277(4 Pt 1):C766-C776
23. Reimer WJ, Dixon SJ (1992) Extracellular nucleotides elevate [Ca2+]i in rat osteoblastic cells by interaction with two receptor subtypes. Am J Physiol 263(5 Pt 1):C1040-C1048
24. Schofl C, Cuthbertson KSR, Walsh CA, Mayne C, Cobbold P, von zur Muhlen A et al (1994) Evidence for P2-purinoceptors on human osteoblast-like cells. J Bone Miner Res 7:485-491
25. Yu H, Ferrier J (1993) Osteoblast-like cells have a variable mixed population of purino/nucleotide receptors. FEBS Lett 328:209-214
26. Gallinaro BJ, Reimer WJ, Dixon SJ (1995) Activation of protein kinase C inhibits ATP-induced [Ca2+]i elevation in rat osteoblastic cells: selective effects on P2Y and P2U signaling pathways. J Cell Physiol 162(3):305-314
27. Bowler WB, Birch MA, Gallagher JA, Bilbe G (1995) Identification and cloning of human P2U purinoceptor present in osteoclastoma, bone, and osteoblasts. J Bone Miner Res 10:1137-1145
28. Hoebertz A, Townsend-Nicholson A, Glass R, Burnstock G, Arnett TR (2000) Expression of P2 receptors in bone and cultured bone cells. Bone 27(4):503-510
29. Jørgensen NR, Geist ST, Civitelli R, Steinberg TH (1997) ATP- and gap junction-dependent intercellular calcium signaling in osteoblastic cells. J Cell Biol 139:497-506
30. 7 receptor by a subpopulation of human osteoblasts. J Bone Miner Res 16(5):846-856
31. 7 nucleotide receptor mediates skeletal mechanotransduction. J Biol Chem 280(52):42952-42959
32. 7 and inhibits osteoclast formation in RAW cells. Am J Physiol Cell Physiol 287(2):C403-C412